Literature DB >> 31526964

Effect of whole-course nutrition management on patients with esophageal cancer undergoing concurrent chemoradiotherapy: A randomized control trial.

Yanfang Qiu1, Jie You2, Kunlun Wang3, Yuan Cao4, Youchun Hu4, Han Zhang4, Rong Fu4, Yafei Sun4, Huanan Chen4, Ling Yuan3, Quanjun Lyu5.   

Abstract

OBJECTIVES: Malnutrition is the most common complication of patients with esophageal cancer and can lead to poor prognosis and death. Good nutritional status has been shown to help improve patient outcomes and reduce complications. In the absence of specific evidence on the effect of nutrition in patients with esophageal cancer, the purpose of this study was to investigate the effect of whole-course nutrition management on the prognosis and complications of chemoradiotherapy in patients with esophageal cancer through a randomized controlled trial.
METHODS: A total of 96 patients with esophageal cancer treated with concurrent chemoradiation were randomized to an intervention group (treated with whole-course nutrition management from the Nutrition Support Team) and a control group (treated with the general nutritional method) for approximately 6 wk. Dietary surveys and body measurements were conducted at baseline and every day thereafter. Patient-generated Subjective Global Assessment score, blood index, quality of life, and psychological condition were assessed at baseline and every week before discharge. Complications (e.g., radiation esophagitis, myelosuppression, and skin symptoms), completion rates of therapy, short-term efficacy evaluation, as well as clinical outcomes were measured.
RESULTS: A total of 85 patients completed the study (intervention group = 45; control group = 40). There were significant differences in the changes of serum albumin and total protein between the two groups throughout the trial (P < 0.05). Complications (e.g., radioactive esophagitis, skin symptom of complications) and quality of life were statistically different before and after the intervention (P < 0.05). The difference in the change of other indicators was not statistically significant.
CONCLUSIONS: Whole-course nutrition management can improve the nutritional status of patients with esophageal cancer treated with concurrent chemoradiotherapy, reduce the severity of radiation esophagitis and radiation skin reactions, improve the quality of life, and relieve depressive symptoms.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complications; Concurrent chemoradiotherapy; Esophageal cancer; Nutrition support team; Nutritional status; Patient-generated Subjective Global Assessment

Mesh:

Year:  2019        PMID: 31526964     DOI: 10.1016/j.nut.2019.110558

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  13 in total

Review 1.  Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adults.

Authors:  Christine Baldwin; Marian Ae de van der Schueren; Hinke M Kruizenga; Christine Elizabeth Weekes
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

2.  Baseline nutritional status could be a predictor for radiation esophagitis in esophageal cancer patients undergoing radiotherapy.

Authors:  Jie Dong; Wencheng Zhang; Tian Zhang; Xi Chen; Jingjing Zhao; Yaqi Zeng; Yajun Chen; Xiaoying Wei; Tongda Lei; Ping Wang; Lujun Zhao; Jun Wang; Zhiyong Yuan; Yongchun Song; Ningbo Liu; Kun Wang; Qingsong Pang
Journal:  Ann Transl Med       Date:  2020-09

3.  Perceptions and experiences of nutritional management needs for patients with esophageal cancer during the peri-radiotherapy period: A qualitative study.

Authors:  Peiru Wang; Xiang Zheng; Zebing Luo; Yiru Wang; Zhijun Guo; Yuhua Zhou
Journal:  Asia Pac J Oncol Nurs       Date:  2022-01-21

4.  The Impact of Weight Loss during Chemoradiotherapy for Unresectable Esophageal Cancer: Real-World Results.

Authors:  Tzu-Ting Huang; Shang-Yu Chou; Yun-Hsuan Lin; Shau-Hsuan Li; Yen-Hao Chen; Hung-I Lu; Chien-Ming Lo; Fu-Min Fang; Yi-Chun Chiu; Yeh-Pin Chou; Yu-Ming Wang
Journal:  Life (Basel)       Date:  2022-05-08

5.  Malnutrition and its associated factors among elderly Chinese with physical functional dependency.

Authors:  Hongting Ning; Yan Du; Donna Ellis; Hong-Wen Deng; Hengyu Hu; Yinan Zhao; Huijing Chen; Lulu Liao; Mengqi Li; Linlin Peng; Hui Feng
Journal:  Public Health Nutr       Date:  2020-05-11       Impact factor: 4.022

6.  Controlling nutritional status score as a prognostic marker to predict overall survival in resected biliary tract cancers.

Authors:  Lejia Sun; Si Su; Jianping Xiong; Wenmo Hu; Lei Liu; Haifeng Xu; Shunda Du; Haitao Zhao; Xin Lu; Xinting Sang; Shouxian Zhong; Huayu Yang; Yilei Mao
Journal:  Ann Transl Med       Date:  2021-04

7.  Development and Validation of a Nomogram Model Based on Hematological Indicators for Predicting the Prognosis of Diffused Gliomas.

Authors:  Song Han; Fang-Wen Qu; Peng-Fei Wang; Ying-Xin Liu; Shou-Wei Li; Chang-Xiang Yan
Journal:  Front Surg       Date:  2022-04-13

8.  Sarcopenia may Influence the Prognosis in Advanced Thyroid Cancer Patients Treated With Molecular Targeted Therapy.

Authors:  Akihiro Nishiyama; Yukiko Staub; Yukio Suga; Mikiya Fujita; Azusa Tanimoto; Koushiro Ohtsubo; Seiji Yano
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.406

9.  Validation of the efficacy of the NUTRISCORE for the nutritional screening of cancer patients in China.

Authors:  Junren Kang; Hailong Li; Xiaodong Shi; Enling Ma; Wei Chen
Journal:  BMC Cancer       Date:  2022-01-06       Impact factor: 4.430

10.  Effects of Enteral Nutrition on Patients With Oesophageal Carcinoma Treated With Concurrent Chemoradiotherapy: A Prospective, Multicentre, Randomised, Controlled Study.

Authors:  Jiahua Lyu; Anhui Shi; Tao Li; Jie Li; Ren Zhao; Shuchai Zhu; Jianhua Wang; Ligang Xing; Daoke Yang; Conghua Xie; Liangfang Shen; Hailin Zhang; Guangying Zhu; Jing Wang; Wenyan Pan; Fang Li; Jinyi Lang; Hanping Shi
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.